Evidence map›Paper›PMID 15452224›Full record

ArticleJournal of virology2004

Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.

Roberta L DeBiasi, Bridget A Robinson, Barbara Sherry, Ron Bouchard, R Dale Brown, Mona Rizeq, Carlin Long, Kenneth L Tyler

Abstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cell Killing by Reovirus: Mechanisms and Consequences.Current topics in microbiology and immunology · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Reovirus receptors, cell entry, and proapoptotic signaling.Advances in experimental medicine and biology · 2013
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Roberta L DeBiasiPediatrics (Infectious Diseases), University of Colorado Health Sciences Center, 4200 East 9th Avenue, Box B055, Denver, CO 80262, USA. roberta.debiasi@uchsc.edu
Bridget A Robinson
Barbara Sherry
Ron Bouchard
R Dale Brown
Mona Rizeq
Carlin Long
Kenneth L Tyler
Neurology, Inc · USNorth Carolina State University · USUnited States Department of Veterans Affairs · USUniversity of Colorado Health · US

Funding

CYTOKINE EXPRESSION IN HUMAN &EXPERIMENTAL HEART FAILURR01HL066399 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LONG, CARLIN S · 2001 to 2004
$935k
Apoptotic Signaling in Viral MyocarditisK08AI052261 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DEBIASI, ROBERTA LYNN · 2002 to 2007
$605k
NHLBI NIH HHS HL 66399NHLBI NIH HHS R01 HL066399NIAID NIH HHS 5K08 AI 052261-02NIAID NIH HHS K08 AI052261
6 · The paper itself

Abstract

Viral myocarditis is a disease with a high morbidity and mortality. The pathogenesis of this disease remains poorly characterized, with components of both direct virus-mediated and secondary inflammatory and immune responses contributing to disease. Apoptosis has increasingly been viewed as an important mechanism of myocardial injury in noninfectious models of cardiac disease, including ischemia and failure. Using a reovirus murine model of viral myocarditis, we characterized and targeted apoptosis as a key mechanism of virus-associated myocardial injury in vitro and in vivo. We demonstrated caspase-3 activation, in conjunction with terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling and annexin binding, in cardiac myocytes after myocarditic viral infection in vitro. We also demonstrated a tight temporal and geographical correlation between caspase-3 activation, histologic injury, and viral load in cardiac tissue after myocarditic viral infection in vivo. Two pharmacologic agents that broadly inhibit caspase activity, Q-VD-OPH and Z-VAD(OMe)-FMK, effectively inhibited virus-induced cellular death in vitro. The inhibition of caspase activity in vivo by the use of pharmacologic agents as well as genetic manipulation reduced virus-induced myocardial injury by 40 to 60% and dramatically improved survival in infected caspase-3-deficient animals. This study indicates that apoptosis plays a critical role in mediating cardiac injury in the setting of viral myocarditis and is the first demonstration that caspase inhibition may serve as a novel therapeutic strategy for this devastating disease.

Indexed as

Caspase InhibitorsAnimalsApoptosisCaspase 3CaspasesHeartHumansMiceMice, Inbred C57BLMice, KnockoutMyocarditisMyocardiumReoviridaeViral LoadCASP3 protein, humanCasp3 protein, mouseCaspase 3Caspase InhibitorsCaspases

Identifiers

PMID15452224
PMCPMC521817
OpenAlexW2065987922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.